Allergan: Application published: “Androgen Composition for Treating an Opthalmic [sic] Condition”

July 6, 2017: The USPTO today published a patent application filed by Allergan, Inc. of Irvine, CA: U.S. Application Publication No. 2017/0189412, “Androgen Composition for Treating an Opthalmic [sic] Condition”.

According to the published abstract:

The disclosure provides compositions for treating an ocular condition. The composition comprises a physiologically effective amount of an androgen, wherein the composition is suitable for topical administration to an eye. The disclosure further provides methods for treating an ocular condition with the disclosed compositions.

The published application can be viewed at the USPTO website at

Note: A published application is not an issued patent. The USPTO automatically publishes most applications 18 months after filing, and the publication is simply a copy of the as-filed application, without examination.